中国保健营养(中旬刊)
中國保健營養(中旬刊)
중국보건영양(중순간)
China Hwalth Care & nutrition
2014年
6期
3467-3468
,共2页
贲门腺癌%手术/局部化疗%腹腔灌注%预后
賁門腺癌%手術/跼部化療%腹腔灌註%預後
분문선암%수술/국부화료%복강관주%예후
Adenocarcinoma of gastric cardia%Operation,Systemic/partial chemotherapy%abdominal cavity perfusion%Influence
目的:探讨贲门腺癌术中综合治疗对患者预后的影响。方法:将中晚期患者随机分为常规治疗A组(单纯行根治术)和实验治疗B组(在根治手术同时行术中全身化疗、癌床局部化疗及胸腹腔温热化疗IPHC)两组,观察其并发症的发生率、复发转移率、生存率的差别。结果:两组术后并发症发生率无明显差异(p>0.05),实验组3年生存率远高于常规治疗组(p<0.01),而复发转移率明显低于常规治疗组(p<0.01)。结论:贲门腺癌术中综合治疗对预后有重要意义,明显降低术中复发率,可提高患者生存率。
目的:探討賁門腺癌術中綜閤治療對患者預後的影響。方法:將中晚期患者隨機分為常規治療A組(單純行根治術)和實驗治療B組(在根治手術同時行術中全身化療、癌床跼部化療及胸腹腔溫熱化療IPHC)兩組,觀察其併髮癥的髮生率、複髮轉移率、生存率的差彆。結果:兩組術後併髮癥髮生率無明顯差異(p>0.05),實驗組3年生存率遠高于常規治療組(p<0.01),而複髮轉移率明顯低于常規治療組(p<0.01)。結論:賁門腺癌術中綜閤治療對預後有重要意義,明顯降低術中複髮率,可提高患者生存率。
목적:탐토분문선암술중종합치료대환자예후적영향。방법:장중만기환자수궤분위상규치료A조(단순행근치술)화실험치료B조(재근치수술동시행술중전신화료、암상국부화료급흉복강온열화료IPHC)량조,관찰기병발증적발생솔、복발전이솔、생존솔적차별。결과:량조술후병발증발생솔무명현차이(p>0.05),실험조3년생존솔원고우상규치료조(p<0.01),이복발전이솔명현저우상규치료조(p<0.01)。결론:분문선암술중종합치료대예후유중요의의,명현강저술중복발솔,가제고환자생존솔。
Objective:Investigate the influence on prognosis of combined therapy for adenocarcinoma of gastric cardia.Methods:To divide the advanced stage patients randomly into two groups A and B.To practise radical correction purely in group A and practise radical correction accompanied with intraoperative chemotherapy, partial chemotherapy of tumor surrounding and IPHC of thoracic and abdominal cavity in group B. To observe the differences of incidence rate relapse and metastasis rate and survival rate between the to groups. Results:The difference of incidence rate of complication between them is not significant (p>0.05).The survival rate of group B is much higher than that of group A (p<0.01) while the relapse and metastasis rate is much lower (p<0.01).Conclusion:The combined therapy for adenocarcinoma of gastric cardia is greatly recommended in prognosis. It markedly reduces the relapse and metastasis rate and incerases the survival rate of the patients after therapy.